SULTRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sultrin, and when can generic versions of Sultrin launch?
Sultrin is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in SULTRIN is triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole). There are five drug master file entries for this compound. Additional details are available on the triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULTRIN?
- What are the global sales for SULTRIN?
- What is Average Wholesale Price for SULTRIN?
Summary for SULTRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 93 |
| DailyMed Link: | SULTRIN at DailyMed |
US Patents and Regulatory Information for SULTRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | SULTRIN | triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) | CREAM;VAGINAL | 005794-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ortho Mcneil Pharm | SULTRIN | triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) | TABLET;VAGINAL | 005794-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
